291 related articles for article (PubMed ID: 35117843)
1. PTPRO predicts patient prognosis and correlates with immune infiltrates in human clear cell renal cell carcinoma.
Gan J; Zhang H
Transl Cancer Res; 2020 Aug; 9(8):4800-4810. PubMed ID: 35117843
[TBL] [Abstract][Full Text] [Related]
2. HJURP is a prognostic biomarker for clear cell renal cell carcinoma and is linked to immune infiltration.
Zhang F; Yuan D; Song J; Chen W; Wang W; Zhu G; Hu B; Chen X; Zhu J
Int Immunopharmacol; 2021 Oct; 99():107899. PubMed ID: 34217993
[TBL] [Abstract][Full Text] [Related]
3.
Cheng X; Sun D; Li H; Zhang J; Luo Q; Jin X; Chen Y; Yuan Q; Wang B
Transl Androl Urol; 2023 Apr; 12(4):642-658. PubMed ID: 37181237
[TBL] [Abstract][Full Text] [Related]
4. NUDT1 Could Be a Prognostic Biomarker and Correlated with Immune Infiltration in Clear Cell Renal Cell Carcinoma.
Lin Y; Zhang F; Jin Y; Zhong Q; Tan W; Liu J; Wu Z
Appl Bionics Biomech; 2022; 2022():3669296. PubMed ID: 36606241
[TBL] [Abstract][Full Text] [Related]
5. Upregulated GSDMB in Clear Cell Renal Cell Carcinoma Is Associated with Immune Infiltrates and Poor Prognosis.
Cui Y; Zhou Z; Chai Y; Zhang Y
J Immunol Res; 2021; 2021():7753553. PubMed ID: 34957313
[TBL] [Abstract][Full Text] [Related]
6.
Wang B; Liu B; Luo Q; Sun D; Li H; Zhang J; Jin X; Cheng X; Niu J; Yuan Q; Chen Y
Transl Cancer Res; 2022 Jul; 11(7):2321-2337. PubMed ID: 35966310
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 20 receptor subunit beta (IL20RB) predicts poor prognosis and regulates immune cell infiltration in clear cell renal cell carcinoma.
Zhang H; Liu Y; Wang B; Wang C
BMC Genom Data; 2022 Jul; 23(1):58. PubMed ID: 35883015
[TBL] [Abstract][Full Text] [Related]
8. ALDOB represents a potential prognostic biomarker for patients with clear cell renal cell carcinoma.
Shao Y; Wu B; Yang Z; Liu Z; Ma Y; Huang H; Liu Y; Wang Z; Hu W; Wang Y; Niu Y
Transl Androl Urol; 2023 Apr; 12(4):549-571. PubMed ID: 37181232
[TBL] [Abstract][Full Text] [Related]
9. PBRM1 mutation and WDR72 expression as potential combinatorial biomarker for predicting the response to Nivolumab in patients with ccRCC: a tumor marker prognostic study.
Chang Q; Sun J; Zhao S; Li L; Zhang N; Yan L; Fan Y; Liu J
Aging (Albany NY); 2023 Nov; 15(23):13753-13775. PubMed ID: 38048211
[TBL] [Abstract][Full Text] [Related]
10. ADAM metallopeptidase domain 12 overexpression correlates with prognosis and immune cell infiltration in clear cell renal cell carcinoma.
Gao J; Yang D; Xu H; Yang K; Ma J; Xia J; Pan X
Bioengineered; 2022 Feb; 13(2):2412-2429. PubMed ID: 35094638
[TBL] [Abstract][Full Text] [Related]
11. A comprehensive analysis of the prognostic value and immune infiltration of low expression DBT in clear cell renal cell carcinoma.
Xie W; Xi P; Liu Y; Zhang Z; Sun T
Front Pharmacol; 2022; 13():1002588. PubMed ID: 36299888
[No Abstract] [Full Text] [Related]
12. The Downregulation of Prognosis- and Immune Infiltration-Related Gene CYFIP2 Serves as a Novel Target in ccRCC.
Tong J; Meng X; Lv Q; Yuan H; Li W; Xiao W; Zhang X
Int J Gen Med; 2021; 14():6587-6599. PubMed ID: 34703279
[TBL] [Abstract][Full Text] [Related]
13. Systematic analyses of the role of prognostic and immunological EIF3A, a reader protein, in clear cell renal cell carcinoma.
Zhang Y; Hua X; Shi H; Zhang L; Xiao H; Liang C
Cancer Cell Int; 2021 Dec; 21(1):680. PubMed ID: 34923969
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance and oncogenic function of NR1H4 in clear cell renal cell carcinoma.
Huang S; Hou Y; Hu M; Hu J; Liu X
BMC Cancer; 2022 Sep; 22(1):995. PubMed ID: 36123627
[TBL] [Abstract][Full Text] [Related]
15. Exploration of the relationships between tumor mutation burden with immune infiltrates in clear cell renal cell carcinoma.
Zhang C; Li Z; Qi F; Hu X; Luo J
Ann Transl Med; 2019 Nov; 7(22):648. PubMed ID: 31930049
[TBL] [Abstract][Full Text] [Related]
16. The Immune-Related Gene HCST as a Novel Biomarker for the Diagnosis and Prognosis of Clear Cell Renal Cell Carcinoma.
Zhou Y; Wang X; Zhang W; Liu H; Liu D; Chen P; Xu D; Liu J; Li Y; Zeng G; Li M; Wu Z; Zhang Y; Wang X; DiSanto ME; Zhang X
Front Oncol; 2021; 11():630706. PubMed ID: 33968730
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of MAX dimerization protein 3 (MXD3) predicts poor prognosis in clear cell renal cell carcinoma.
Zhang F; Liu L; Wu P; Li S; Wei D
Transl Androl Urol; 2021 Feb; 10(2):785-796. PubMed ID: 33718080
[TBL] [Abstract][Full Text] [Related]
18. Bioinformatics screening of prognostic immune-related genes in renal clear cell carcinoma.
Cui K; Song H; Zhang H; Sun P
J Appl Genet; 2024 May; ():. PubMed ID: 38780866
[TBL] [Abstract][Full Text] [Related]
19. A comprehensive analysis of MYO6 as a promising biomarker for diagnosis, prognosis, and immunity in clear cell renal cell carcinoma.
Meng W; Chen B; Jiang Z; Cai B; Ma L; Guan Y
Transl Cancer Res; 2023 Aug; 12(8):2071-2098. PubMed ID: 37701098
[TBL] [Abstract][Full Text] [Related]
20. Decreased
Chen Z; Lv Y; He L; Wu S; Wu Z
Front Mol Biosci; 2021; 8():657672. PubMed ID: 35096961
[No Abstract] [Full Text] [Related]
[Next] [New Search]